Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Potential pharmacy closure might benefit another pharmacist

Graham Phillips’s excellent and passionate letter about the future of his Southdown, Harpenden, Hertfordshire pharmacy (The Pharmaceutical Journal 2016;297:294) illustrates the quandary proprietor pharmacists have.

Before I retired, I had a small chain of pharmacies that were arbitrarily classified as independent but, in fact, were small multiples with few of the advantages (e.g. little economy of scale, less sophisticated IT) compared with our larger multiple colleagues. However, as practising owners we can ensure our pharmacies are customer focused and pharmacy centred rather than system driven.

In Phillips’s case, even from the few facts he has given in his letter, one can deduce that the Southdown pharmacy is probably not contributing much to the balance sheet of his company, although it is undoubtedly an invaluable healthcare facility to his community.

The end of a lease gives the landlord and tenant the opportunity to decide whether to continue with the current tenancy. I am sure he has been considering his options for some months and, as he points out, the funding cuts have weighted the scales in favour of closure. However, if he closes he will gain nothing except perhaps some of the Southdown pharmacy prescriptions transferring to his other Harpenden pharmacy.

In my experience, a true independent — a pharmacist proprietor manager — would be able to improve the viability of a discarded branch of a multiple. There are many newly registered pharmacists waiting for an opportunity to own their own pharmacy, but goodwill prices are often prohibitive.

Perhaps Phillips now has the chance to give such a person a wonderful opportunity and any nominal goodwill funds he achieves would be a bonus to his company.

Barry Shooter

Bushey Heath,


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20202022

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.